Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Molecular Cell
|
January 25, 2025
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth
Dong Guo, Qiujing Yu, Yingying Tong, et al.
Signal Transduction and Targeted Therapy
|
May 24, 2026
Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis
Yongqiang Wang, Xiangyang Zhang, Ningning Wang, et al.
Nature Chemical Biology
|
January 29, 2025
ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation
Lei Wang, Runze Shi, Shuo Wang, et al.
The Journal of Experimental Medicine
|
March 6, 2025
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion
Wenxing Qin, Yuran Duan, Zhiqiang Hu, et al.
Nature Cancer
|
February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways
Min Li, Xuxiao He, Weixing Guo, et al.
Nature Cancer
|
November 4, 2025
Author Correction: Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways
Min Li, Xuxiao He, Weixing Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2025
Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner
Xu Qian, Qimin Zhou, Yuan Ouyang, et al.
Nature Chemical Biology
|
April 25, 2025
PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation
Peixiang Zheng, Zhiqiang Hu, Yuli Shen, et al.
Journal of Medicinal Chemistry
|
June 22, 2026
Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 Inhibitors
Vishal A Verma, Jessica M Grandner, Brendan T Parr, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Molecular Cell
|
January 25, 2025
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth
Dong Guo, Qiujing Yu, Yingying Tong, et al.
Signal Transduction and Targeted Therapy
|
May 24, 2026
Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis
Yongqiang Wang, Xiangyang Zhang, Ningning Wang, et al.
Nature Chemical Biology
|
January 29, 2025
ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation
Lei Wang, Runze Shi, Shuo Wang, et al.
The Journal of Experimental Medicine
|
March 6, 2025
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion
Wenxing Qin, Yuran Duan, Zhiqiang Hu, et al.
Nature Cancer
|
February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways
Min Li, Xuxiao He, Weixing Guo, et al.
Nature Cancer
|
November 4, 2025
Author Correction: Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways
Min Li, Xuxiao He, Weixing Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2025
Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner
Xu Qian, Qimin Zhou, Yuan Ouyang, et al.
Nature Chemical Biology
|
April 25, 2025
PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation
Peixiang Zheng, Zhiqiang Hu, Yuli Shen, et al.
Journal of Medicinal Chemistry
|
June 22, 2026
Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 Inhibitors
Vishal A Verma, Jessica M Grandner, Brendan T Parr, et al.
Page
of 7